Unknown

Dataset Information

0

Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults.


ABSTRACT: Folic acid (FA) supplementation facilitates urinary excretion of arsenic, a human carcinogen. A better understanding of interactions between one-carbon metabolism intermediates may improve the ability to design nutrition interventions that further facilitate arsenic excretion.The objective was to determine if FA and/or creatine supplementation increase choline and betaine and decrease dimethylglycine (DMG).We conducted a secondary analysis of the Folic Acid and Creatine Trial, a randomized trial in arsenic-exposed Bangladeshi adults (n = 605, aged 24-55 y, 50.3% male) who received arsenic-removal water filters. We examined treatment effects of FA and/or creatine supplementation on plasma choline, betaine, and DMG concentrations, measured by LC-tandem mass spectrometry at baseline and at week 12. Group comparisons were between 1) 400 and 800 ?g FA/d (FA400 and FA800, respectively) compared with placebo, 2) creatine (3 g/d) compared with placebo, and 3) creatine plus FA400 compared with FA400.Choline decreased in the placebo group (-6.6%; 95% CI: -10.2%, -2.9%) but did not change in the FA groups (FA400: 2.5%; 95% CI: -0.9%, 6.1%; FA800: 1.4%; 95% CI: -2.5%, 5.5%; P < 0.05). Betaine did not change in the placebo group (-3.5%; 95% CI: -9.3%, 2.6%) but increased in the FA groups (FA400: 14.1%; 95% CI: 9.4%, 19.0%; FA800: 13.0%; 95% CI: 7.2%, 19.1%; P < 0.01). The decrease in DMG was greater in the FA groups (FA400: -26.7%; 95% CI: -30.9%, -22.2%; FA800: -27.8%; 95% CI: -31.8%, -23.4%) than in the placebo group (-12.3%; 95% CI: -18.1%, -6.2%; P < 0.01). The percentage change in choline, betaine, and DMG did not differ between creatine treatment arms and their respective reference groups.Supplementation for 12 wk with FA, but not creatine, increases plasma betaine, decreases plasma DMG, and prevents a decrease in plasma choline in arsenic-exposed Bangladeshi adults. This trial was registered at clinicaltrials.gov as NCT01050556.

SUBMITTER: Hall MN 

PROVIDER: S-EPMC4841924 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Supplementation with Folic Acid, but Not Creatine, Increases Plasma Betaine, Decreases Plasma Dimethylglycine, and Prevents a Decrease in Plasma Choline in Arsenic-Exposed Bangladeshi Adults.

Hall Megan N MN   Howe Caitlin G CG   Liu Xinhua X   Caudill Marie A MA   Malysheva Olga O   Ilievski Vesna V   Lomax-Luu Angela M AM   Parvez Faruque F   Siddique Abu B AB   Shahriar Hasan H   Uddin Mohammad N MN   Islam Tariqul T   Graziano Joseph H JH   Gamble Mary V MV  

The Journal of nutrition 20160406 5


<h4>Background</h4>Folic acid (FA) supplementation facilitates urinary excretion of arsenic, a human carcinogen. A better understanding of interactions between one-carbon metabolism intermediates may improve the ability to design nutrition interventions that further facilitate arsenic excretion.<h4>Objective</h4>The objective was to determine if FA and/or creatine supplementation increase choline and betaine and decrease dimethylglycine (DMG).<h4>Methods</h4>We conducted a secondary analysis of  ...[more]

Similar Datasets

| S-EPMC10045040 | biostudies-literature
| S-EPMC7685552 | biostudies-literature
| S-EPMC10675502 | biostudies-literature
| S-EPMC6367980 | biostudies-literature
| S-EPMC4671237 | biostudies-literature
| S-EPMC4102310 | biostudies-literature
| S-EPMC11316459 | biostudies-literature
| S-EPMC9731106 | biostudies-literature
| S-EPMC4330557 | biostudies-literature
| S-EPMC6862747 | biostudies-literature